SCHEMBL14670652

SCHEMBL14670652

Cc1cc(Nc2ncc(Cl)c(N)n2)n[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ JAK2 O60674 6/20 0.49
▸ FGFR1 P11362 5/20 0.49
▸ AURKA O14965 5/20 0.49
▸ IGF1R P08069 5/20 0.49
▸ JAK3 P52333 5/20 0.49
▸ PAK4 O96013 4/20 0.49
▸ KDR P35968 4/20 0.49
▸ PLK4 O00444 3/20 0.49
▸ NTRK1 P04629 2/20 0.49
▸ RET P07949 2/20 0.49
▸ FLT3 P36888 2/20 0.49
▸ PTK2 Q05397 2/20 0.49
▸ TNK2 Q07912 2/20 0.49
▸ AURKB Q96GD4 2/20 0.49
▸ STK10 O94804 1/20 0.49
▸ FER P16591 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14670395 0.79 IGF1R (0.60) IGF1R
SCHEMBL4005596 0.74 MEN1 (0.59) MEN1HTTKMT2AHSD17B10JAK2
SCHEMBL218642 0.74 MEN1 (0.62) MEN1HTTKMT2AHSD17B10JAK2
SCHEMBL17501771 0.74 ITK (0.50) MEN1HTTKMT2AHSD17B10JAK2
SCHEMBL3939475 0.73 PAK4 (0.56) MEN1HTTKMT2AHSD17B10JAK2
SCHEMBL29784035 0.72 JAK2 (0.57) MEN1HTTKMT2AHSD17B10JAK2
SCHEMBL3869550 0.70 ITK (0.51) MEN1HTTKMT2AHSD17B10JAK2
SCHEMBL4168909 0.70 IKBKB (0.46) MEN1HTTKMT2AHSD17B10JAK2
SCHEMBL1822366 0.70 KDR (0.42) MEN1KMT2AJAK2AURKAIGF1R
SCHEMBL4164963 0.69 MEN1 (0.49) MEN1HTTKMT2AHSD17B10AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013014162-A1 HETEROCYCLYL PYRIMIDINE ANALOGUES AS JAK INHIBITORS CELLZOME LIMITED (GB) 2013-01-31 — — WO disclosed
Send feedback